跳至主要内容
临床试验/JPRN-jRCTs052210155
JPRN-jRCTs052210155已完成1 期

Active Thermo-Therapy for Arthritis with stiffness Caused by Rheumatoid Arthritis - ATTACA study

Shima Yoshihito0 个研究点目标入组 20 人开始时间: 2022年1月17日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 < 90age old(—)
性别
All

入选标准

  • 1. Patients over 20 years old and under 90 years old when the consent is obtained.
  • 2.Patients who were diagnosed with rheumatoid arthritis (RA) by the 2010 EULAR-ACR classification criteria for rheumatoid arthritis.
  • 3.Patients who usually have Morning Stiffness (MS) on their hands for 15 minutes or longer.
  • 4.Patients who have not changed or started the treatment for RA within 4 weeks prior to the consent.
  • 5.Patients who give written informed consent.
  • 6.Patients currently attending the department of clinical immunology, Osaka University Hospital.

排除标准

  • 1.Patients who have any skin disease at the site of wearing the warmer.
  • 2.Patiens under chronic febrile disease including infectious disease.
  • 3.Patients who have diabetes mellitus.
  • 4.Patients who have peripheral neuropathy of upper extremities.
  • 5.Patients who are incapable of wearing or taking off the warmer by themselves.
  • 6.Patients who have vascular shunt on the arm for hemodialysis.
  • 7.Other Patients who are judged as ineligible by the responsible researcher.

研究者

发起方
Shima Yoshihito

相似试验

尚未招募
4 期
Innovative Approaches to Inflammatory Arthritis: Efficacy and Safety of non-invasive transcutaneous auricular vagus nerve stimulation (IA-taVNS)Rheumatoid arthritis, Spondyloarthritis
JPRN-UMIN000053649Hokkaido University20
已完成
不适用
Study for laser therapy against arthritis in patients with rheumatoid arthritis.Rheumatoid arthritis
JPRN-UMIN000021640Institute of Medical Science, St. Marianna University School of Medicine15
进行中(未招募)
1 期
Comparing the effectiveness of tofacitinib extended release (XR) chronotherapy, morning versus evening dosing, in rheumatoid arthritis (RA) and psoriatic arthritis (PsA) patients from a patient’s, clinical as well as a translational point of view.Rheumatoid arthritis or psoriatic arthritis according to respectively 2010 criteria or CASPAR criteriaMedDRA version: 23.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 21.0Level: LLTClassification code 10037160Term: Psoriatic arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disorders
EUCTR2021-004131-84-NLErasmus Medical Center84
招募中
4 期
Chronotherapy in Inflammatory Arthritis (ChronIA trial): a randomized controlled trial comparing the effectiveness of morning and evening dosing of tofacitinib extended-releaseInflammatory ArthirtisJoint inflammatoin10013361
NL-OMON52175Erasmus MC, Universitair Medisch Centrum Rotterdam84
进行中(未招募)
不适用
Treatment of osteoarthritis with allogeneic mesenchymal cells (MSV*).gonarthrosis (osteoarthritis)MedDRA version: 14.1Level: LLTClassification code 10048794Term: GonarthrosisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disorders
EUCTR2011-005321-51-ESParque Científico de la Universidad de Valladolid30